July 28, 2008
MindfulEye, Inc. Receives Purchase Order for Natural Joint and Inflammation Product
MindfulEye, Inc. (Pinksheets: MEYN) is pleased to announce that it has received its first purchase order from regional supplement retailer, The Vitamin Guy.
The Vitamin Guy is a well respected retailer, with innovative and cutting edge supplements, that cater to all aspects of nutrition and healthcare. The Vitamin Guy has submitted a Purchase Order to acquire the Arthrizyme product, which is innovative in its ability to assist the body in inflammation and general joint pain.
"The Vitamin Guy is very aggressive in its marketing of its nutritional and healthcare products, through their very educated and well-informed staff and we are very pleased that The Vitamin Guy will offer our valued products to their esteemed and no doubt loyal customers," states Harvey Panesar, President of MindfulEye, Inc. "Although The Vitamin Guy may not be as large as some of its competitors, they are very well respected for their knowledge in the nutrition and healthcare market."
"Although we have shifted our focus onto the infomercial and becoming more of media presence with the Medical Crisis book, we are very pleased at the continued interest retailers have shown in our products and the willingness to sell them," continued Mr. Panesar.
About MindfulEye, Inc
MindfulEye, Inc. has a vision of being a leader in holistic and natural health. MindfulEye, Inc. is pleased to bring effective options to individuals seeking natural and healthy alternatives to general joint care through the Arthrizyme brand, as well as a natural alternative to the weight loss and weight management market through the innovative Vital Slim Plus brand. MindfulEye, Inc. is determined to bring consumers a variety of innovative, natural and effective products, which also include the informative and highly useful book by Dr. Martin, Medical Crisis: Secrets Your Doctor Won't Share With You.
Forward Looking Statements
This release includes forward-looking statements and projections, made in reliance on the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The company has made every reasonable effort to ensure that the information and assumptions on which these statements and projections are based are current, reasonable, and complete. However, a variety of factors could cause actual results to differ materially from the projections, anticipated results or other expectations expressed in this release, including, without limitation, the ability to implement and achieve our objectives in the long-range plan; actions by the credit rating agencies; the successful close of our financing transactions; our ability to divest of certain assets; inability to realize anticipated synergies and cost savings associated with restructurings and divestitures on a timely basis; the uncertainties associated with governmental regulation; the uncertainties associated with the outcome of governmental investigations; the outcome of pending litigation including shareholder derivative and class actions; difficulty in integration of the operations of previously acquired companies, and competition. While the company makes these statements and projections in good faith, neither the company nor its management can guarantee that anticipated future results will be achieved. The company assumes no obligation to publicly update or revise any forward-looking statements made herein or any other forward-looking statements made by the company, whether as a result of new information, future events, or otherwise.